Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hoskin

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 26, 2016
Protocols for Studying Antimicrobial Peptides (AMPs) as Anticancer AgentsLaurence Madera, David W Hoskin
Biochimica Et Biophysica Acta|December 15, 2007
Studies on anticancer activities of antimicrobial peptidesDavid W Hoskin, Ayyalusamy Ramamoorthy
Anticancer Research|May 5, 2005
Paclitaxel inhibits natural killer cell binding to target cells by down-regulating adhesion molecule expressionOsama Loubani, David W Hoskin
Expert Opinion on Investigational Drugs|July 25, 2006
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatmentJamie S Mader, David W Hoskin
Anticancer Research|February 5, 2020
Delivery of Apoptosis-inducing Piperine to Triple-negative Breast Cancer Cells <i>via</i> Co-polymeric NanoparticlesJavad Ghassemi Rad, David W Hoskin
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Assessing the Impact of Phytochemicals on Immune Checkpoints: Implications for Cancer ImmunotherapyMelanie R Power Coombs, David W Hoskin
Advanced Pharmaceutical Bulletin|December 21, 2019
10-Gingerol Inhibits Ovarian Cancer Cell Growth by Inducing G2 ArrestAndrea Rasmussen, Kaylee Murphy, David W Hoskin
Frontiers in Immunology|April 28, 2022
Editorial: Immune Modulation by FlavonoidsDavid W Hoskin, Melanie R Power Coombs
International Immunopharmacology|July 19, 2005
The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model systemRobert T M Boudreau, David W Hoskin
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
Thy-1: more than a mouse pan-T cell markerS M Mansour Haeryfar, David W Hoskin
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|December 26, 2016
Protocols for Studying Antimicrobial Peptides (AMPs) as Anticancer AgentsLaurence Madera, David W Hoskin
Biochimica Et Biophysica Acta|December 15, 2007
Studies on anticancer activities of antimicrobial peptidesDavid W Hoskin, Ayyalusamy Ramamoorthy
Anticancer Research|May 5, 2005
Paclitaxel inhibits natural killer cell binding to target cells by down-regulating adhesion molecule expressionOsama Loubani, David W Hoskin
Expert Opinion on Investigational Drugs|July 25, 2006
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatmentJamie S Mader, David W Hoskin
Anticancer Research|February 5, 2020
Delivery of Apoptosis-inducing Piperine to Triple-negative Breast Cancer Cells <i>via</i> Co-polymeric NanoparticlesJavad Ghassemi Rad, David W Hoskin
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2020
Assessing the Impact of Phytochemicals on Immune Checkpoints: Implications for Cancer ImmunotherapyMelanie R Power Coombs, David W Hoskin
Advanced Pharmaceutical Bulletin|December 21, 2019
10-Gingerol Inhibits Ovarian Cancer Cell Growth by Inducing G2 ArrestAndrea Rasmussen, Kaylee Murphy, David W Hoskin
Frontiers in Immunology|April 28, 2022
Editorial: Immune Modulation by FlavonoidsDavid W Hoskin, Melanie R Power Coombs
International Immunopharmacology|July 19, 2005
The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model systemRobert T M Boudreau, David W Hoskin
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
Thy-1: more than a mouse pan-T cell markerS M Mansour Haeryfar, David W Hoskin
Pageof 13